Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other liabilities (Details)

v3.20.1
Accrued expenses and other liabilities (Details) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Accrued expenses and other liabilities.    
Accrued clinical trial expenses $ 625,964 $ 1,156,618
Compensation and related benefits 115,348 303,870
Other expenses 350,923 215,979
Accrued expenses $ 1,092,235 $ 1,676,467